Patent · US Expired

Near infrared chemiluminescent acridinium compounds and uses thereof

US7083986B2 · kind B2 · utility

12Cited by
22References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 6, 2001
Grant dateAug 1, 2006
Priority date
Expiry dateAug 9, 2022

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/13
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method for the detection or quantitation of an analyte in a biological sample is disclosed. The method comprises the steps of selecting a biological sample suspected of containing a target analyte and binding the target analyte in the sample to a binding partner conjugated to an acridinium compound, wherein the acridinium compound comprises an acridinium nucleus having an electron-donating substituent directly attached to the acridinium nucleus at the C2 position. Chemiluminescent acridinium compounds useful in the method have emission maxima close to or in the near infrared (NIR) region (>590 nm). These chemiluminescent acridinium compounds when used in conjunction with short wavelength-emitting acridinium esters (with emission maxima below 450 nm) can be highly useful labels for the simultaneous detection of multiple target analytes in a single assay.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.